Mastering Breast Cancer Initiative, LLC Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2017
NCT02947685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 7